News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
13,725 Results
Type
Article (777)
Company Profile (18)
Press Release (12929)
Multimedia
Podcasts (2)
Webinars (2)
Section
Business (4499)
Career Advice (17)
Deals (654)
Drug Delivery (2)
Drug Development (2348)
Employer Resources (2)
FDA (221)
Job Trends (277)
News (7258)
Policy (383)
Tag
Academia (37)
Accelerated approval (2)
Adcomms (5)
Allergies (6)
Alliances (1213)
ALS (1)
Alzheimer's disease (13)
Antibody-drug conjugate (ADC) (20)
Approvals (215)
Artificial intelligence (7)
Autoimmune disease (6)
Bankruptcy (4)
Best Places to Work (219)
BIOSECURE Act (5)
Biosimilars (1)
Biotechnology (14)
Bladder cancer (1)
Brain cancer (1)
Breast cancer (2)
Cancer (125)
Cardiovascular disease (12)
Career advice (10)
CAR-T (16)
CDC (1)
Cell therapy (56)
Clinical research (1886)
Collaboration (63)
Compensation (34)
Complete response letters (4)
COVID-19 (103)
CRISPR (7)
C-suite (41)
Cystic fibrosis (1)
Data (170)
Diabetes (13)
Diagnostics (32)
Drug discovery (9)
Drug pricing (1)
Earnings (1502)
Editorial (2)
Employer resources (2)
Events (2546)
Executive appointments (51)
FDA (293)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (48)
Gene editing (12)
Gene therapy (38)
GLP-1 (19)
Government (52)
Guidances (7)
Healthcare (414)
Immunology and inflammation (13)
Immuno-oncology (1)
Infectious disease (105)
Inflammatory bowel disease (10)
Intellectual property (6)
Interviews (3)
IPO (363)
Job creations (62)
Job search strategy (10)
JPM (2)
Kidney cancer (1)
Labor market (5)
Layoffs (20)
Legal (65)
Liver cancer (2)
Lung cancer (18)
Lymphoma (22)
Machine learning (1)
Management (1)
Manufacturing (29)
MASH (2)
Medical device (66)
Medtech (66)
Mergers & acquisitions (320)
Metabolic disorders (21)
Neurodegenerative disease (8)
Neuroscience (27)
NextGen: Class of 2026 (139)
Non-profit (19)
Now hiring (1)
Obesity (6)
Opinion (1)
Ovarian cancer (4)
Pain (9)
Pancreatic cancer (2)
Parkinson's disease (5)
Patents (11)
Patient recruitment (9)
People (1758)
Pharmacy benefit managers (1)
Phase 1 (861)
Phase 2 (926)
Phase 3 (541)
Pipeline (147)
Policy (14)
Postmarket research (25)
Preclinical (286)
Press Release (1)
Prostate cancer (3)
Psychedelics (1)
Radiopharmaceuticals (2)
Rare diseases (38)
Real estate (115)
Recruiting (1)
Regulatory (384)
Reports (3)
Research institute (63)
Resumes & cover letters (3)
RSV (1)
Schizophrenia (3)
Series A (12)
Series B (4)
Service/supplier (1)
Sickle cell disease (2)
Special edition (2)
Spinal muscular atrophy (1)
Sponsored (2)
Startups (105)
Supply chain (2)
Tariffs (2)
The Weekly (2)
Vaccines (16)
Venture capital (4)
Weight loss (3)
Date
Today (1)
Last 7 days (20)
Last 30 days (60)
Last 365 days (817)
2026 (76)
2025 (836)
2024 (1039)
2023 (1281)
2022 (1600)
2021 (1624)
2020 (1243)
2019 (734)
2018 (540)
2017 (661)
2016 (546)
2015 (591)
2014 (397)
2013 (339)
2012 (292)
2011 (296)
2010 (310)
Location
Africa (16)
Asia (1117)
Australia (91)
California (502)
Canada (123)
China (35)
Colorado (3)
Connecticut (9)
Delaware (14)
Europe (1351)
Florida (33)
Idaho (1)
Illinois (7)
India (9)
Indiana (2)
Japan (16)
Maryland (64)
Massachusetts (226)
Michigan (4)
Minnesota (5)
Nevada (1)
New Jersey (73)
New Mexico (1)
New York (40)
North Carolina (18)
Northern California (221)
Oklahoma (1)
Pennsylvania (68)
South America (9)
Southern California (191)
Texas (38)
United States (1101)
Utah (2)
Virginia (1)
Washington D.C. (2)
Washington State (17)
Wisconsin (2)
13,725 Results for "artiva biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November 2025
October 31, 2025
·
3 min read
Press Releases
Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 13, 2025
·
9 min read
Press Releases
Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability of AlloNK in NHL
January 21, 2026
·
4 min read
Press Releases
Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025
August 26, 2025
·
3 min read
Press Releases
Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update
October 17, 2025
·
8 min read
Press Releases
Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease
November 13, 2025
·
9 min read
Press Releases
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®
November 3, 2025
·
4 min read
Press Releases
Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights
August 7, 2025
·
8 min read
Press Releases
Artiva Biotherapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
May 29, 2025
·
3 min read
Press Releases
Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights
May 9, 2025
·
11 min read
1 of 1,373
Next
